{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T18:56:24Z","timestamp":1768416984481,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.07.075","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T01:52:00Z","timestamp":1628301120000},"page":"5447-5450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementing vaccination policies based upon scientific evidence in Japan"],"prefix":"10.1016","volume":"39","author":[{"given":"Tetsushi","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7798","key":"10.1016\/j.vaccine.2021.07.075_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"7798","key":"10.1016\/j.vaccine.2021.07.075_b0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.vaccine.2021.07.075_b0015","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.07.075_b0020","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","author":"Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.07.075_b0025","doi-asserted-by":"crossref","unstructured":"Moore JP, Klasse PJ. COVID-19 Vaccines: \u201cWarp Speed\u201d Needs Mind Melds, Not Warped Minds. J Virol. 2020;94.","DOI":"10.1128\/JVI.01083-20"},{"issue":"7892","key":"10.1016\/j.vaccine.2021.07.075_b0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"304","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.07.075_b0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2021.07.075_b0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.075_b0045","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2021.07.075_b0050","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.07.075_b0055","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep."},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.075_b0060","doi-asserted-by":"crossref","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","article-title":"Global Varicella Vaccine Effectiveness: A Meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.07.075_b0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.75.4.667","article-title":"Long-term protective immunity of recipients of the OKA strain of live varicella vaccine","volume":"75","author":"Asano","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2021.07.075_b0070","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1542\/peds.94.4.524","article-title":"Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine","volume":"94","author":"Asano","year":"1994","journal-title":"Pediatrics"},{"issue":"29","key":"10.1016\/j.vaccine.2021.07.075_b0075","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.vaccine.2016.04.059","article-title":"Development of varicella vaccine in Japan and future prospects","volume":"34","author":"Ozaki","year":"2016","journal-title":"Vaccine."},{"issue":"37","key":"10.1016\/j.vaccine.2021.07.075_b0080","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1016\/j.vaccine.2017.07.090","article-title":"Evaluating the effectiveness of the universal immunization program against varicella in Japanese children","volume":"35","author":"Hattori","year":"2017","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.07.075_b0085","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1016\/j.vaccine.2020.09.038","article-title":"Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan","volume":"38","author":"Hattori","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.07.075_b0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2019.07.009","article-title":"Reliability of direct varicella zoster virus loop-mediated isothermal amplification method for rapid diagnosis of breakthrough varicella","volume":"119","author":"Higashimoto","year":"2019","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.075_b0095","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.braindev.2013.07.013","article-title":"Nationwide survey of rotavirus-associated encephalopathy and sudden unexpected death in Japan","volume":"36","author":"Kawamura","year":"2014","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.075_b0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ped.13506","article-title":"Survey of rotavirus-associated severe complications in Aichi Prefecture","volume":"60","author":"Hattori","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2021.07.075_b0105","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/INF.0000000000001770","article-title":"Rotavirus Genotypes Circulating in Brazil Before and After the National Rotavirus Vaccine Program: A Review","volume":"37","author":"Santos","year":"2018","journal-title":"Pediatr Infect Dis J"},{"issue":"15","key":"10.1016\/j.vaccine.2021.07.075_b0110","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.vaccine.2018.02.064","article-title":"Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program","volume":"36","author":"Isabel","year":"2018","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.07.075_b0115","doi-asserted-by":"crossref","unstructured":"Roczo-Farkas S, Kirkwood CD, Cowley D, Barnes GL, Bishop RF, Bogdanovic-Sakran N, et al. The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data. J Infect Dis. 2018;218:546-54.","DOI":"10.1093\/infdis\/jiy197"},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.075_b0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.vaccine.2017.12.006","article-title":"Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city","volume":"36","author":"Yoshikawa","year":"2018","journal-title":"Japan. Vaccine."},{"issue":"5","key":"10.1016\/j.vaccine.2021.07.075_b0125","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/21645515.2015.1121337","article-title":"Estimating rotavirus vaccine effectiveness in Japan using a screening method","volume":"12","author":"Araki","year":"2016","journal-title":"Hum Vaccin Immunother."},{"issue":"4","key":"10.1016\/j.vaccine.2021.07.075_b0130","first-page":"28","article-title":"Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City","volume":"7","author":"Asada","year":"2016","journal-title":"Japan. Western Pac Surveill Response J."},{"issue":"7","key":"10.1016\/j.vaccine.2021.07.075_b0135","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pds.3800","article-title":"Post-marketing monitoring of intussusception after rotavirus vaccination in Japan","volume":"24","author":"Bauchau","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.vaccine.2021.07.075_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s40264-015-0376-7","article-title":"Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis","volume":"39","author":"Ledent","year":"2016","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.vaccine.2021.07.075_b0145","doi-asserted-by":"crossref","first-page":"e1912458","DOI":"10.1001\/jamanetworkopen.2019.12458","article-title":"Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis","volume":"2","author":"Lu","year":"2019","journal-title":"JAMA Netw Open."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21009683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:01:20Z","timestamp":1759402880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21009683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21009683"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing vaccination policies based upon scientific evidence in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}